| # | % | |||||
|---|---|---|---|---|---|---|
| 4751 | ACTAVIS PLC | 203,900 | 60,685,000 | 0.95% | Call | |
| 4752 | SALIX PHARMACEUTICALS INC | 516,177 | 89,201,000 | 1.40% | ||
| 4753 | ACTAVIS PLC | 492,300 | 146,518,000 | 2.30% | Put | |
| 4754 | SALIX PHARMACEUTICALS INC | 1,183,500 | 204,521,000 | 3.21% | Put | |
| 4755 | SALIX PHARMACEUTICALS INC | 1,415,400 | 244,595,000 | 3.84% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000932540-15-000007, filed 2015.05.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.